Frances Rudnick Levin MD
Addiction
Associate Professor of Psychiatry, Columbia P&S
Join to view full profile
1051 Riverside Drive, Box 66NYSPI, Dept Psychiatry-RFMHNew York, NY 10032
Phone+1 212-543-5896
Dr. Levin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Maryland Medical CenterResidency, 1989 - 1990
New York-Presbyterian HospitalResidency, 1985 - 1988
Weill Cornell MedicineClass of 1985
Certifications & Licensure
NJ State Medical License 2004 - 2027
NY State Medical License 1986 - 2026
MD State Medical License 1988 - 1992
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2011-2014
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
Clinical Trials
Publications & Presentations
PubMed
- Brief report: A cross-sectional survey of provider engagement with family members following patient drug overdose death.Jessica B Calihan, Frances R Levin, Cale N Basaraba, Agata Bereznicka, Kathryn Cates-Wessel
The American Journal on Addictions. 2026-09-01 - 1 citationsWhen Agitation Meets Intoxication: A Retrospective Comparison of Intramuscular Olanzapine and Haloperidol Among Patients With and Without Substance Use in a Psychiatri...Sean T Lynch, Chelsea D Eisenach, Michael T Mangold, Vidushi A Purohit, Lisa J Cohen
Substance Use & Addiction Journal. 2026-07-01 - Beyond abstinence: Redefining success in cannabis use disorder treatment.Tobias B Atkin, Frances R Levin, John Mariani, Christina A Brezing
Addiction. 2026-06-22
Press Mentions
Older Adults with ADHD More Likely to Be Overlooked for Diagnosis, TreatmentSeptember 21st, 2023- Effort Underway to Develop First US Guidelines for ADHD in AdultsApril 17th, 2023
- AELIS FARMA : Announces a Strategic Collaboration and Option-License Agreement with INDIVIOR for the Treatment of Cannabis-Related DisordersJune 8th, 2021
Grant Support
- Translational Clinical Research Fellowship on Substance Use DisordersCOLUMBIA UNIVERSITY HEALTH SCIENCES1993–2028
- Translational Clinical Research Fellowship on Substance Use DisordersCOLUMBIA UNIVERSITY HEALTH SCIENCES1993–2028
- Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorderNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2023–2027
- Phase 1 and 2 studies of sublingual dexmedetomidine, an alpha 2 adrenergic agonist, for treating opioid withdrawalNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2022–2025
- Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse DisorderPHOENIX PHARMALABS, INC.2022–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
